Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3490-3494
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3490
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3490
Oligs produced by H2O2 oxidation | Oligs produced byβ -elimination | Oligs produced by degradation with HNO2 | |||
Samples | Mr | Samples | Mr | Samples | Mr |
Olig H1 | 6032 | Olig B1 | 6621 | Olig N1 | 6680 |
Olig H2 | 3206 | Olig B2 | 3375 | Olig N2 | 3150 |
Olig H3 | 2381 | Olig B3 | 2447 | Olig N3 | 2334 |
Olig H4 | 1786 | Olig B4 | 1804 | Olig N4 | 1747 |
Olig H5 | 1142 | Olig B5 | 1344 | Olig N5 | 1047 |
Olig H6 | 632 | Olig B6 | 702 | Olig N6 | 609 |
- Citation: Ji SL, Cui HF, Shi F, Chi YQ, Cao JC, Geng MY, Guan HS. Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes. World J Gastroenterol 2004; 10(23): 3490-3494
- URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3490.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3490